Caricamento...
cGMP modulation therapeutics for sickle cell disease
Sickle cell disease (SCD) is an inherited disease caused by the production of abnormal hemoglobin (Hb) S, whose deoxygenation-induced polymerization results in red blood cell (RBC) sickling and numerous pathophysiological consequences. SCD affects approximately 300,000 newborns worldwide each year a...
Salvato in:
| Pubblicato in: | Exp Biol Med (Maywood) |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publications
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6405827/ https://ncbi.nlm.nih.gov/pubmed/30691292 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370219827276 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|